No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death

Journal of NeuroVirology

Volumn 21, Issue 1, 2015, Pages 24-31

  Becker, James T ^a,k   Martinson, Jeremy J ^b   Penugonda, Sudhir ^c   Kingsley, Lawrence ^b   Molsberry, Samantha ^a   Reynolds, Sandra ^d   Aronow, Aaron ^e   Goodkin, Karl ^f   Levine, Andrew ^g   Martin, Eileen ^h   Miller, Eric N ⁱ   Munro, Cynthia A ^j   Ragin, Ann ^c   Sacktor, Ned ^j  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f AIDS HEALTHCARE FOUNDATION   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h RUSH MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Neuropsychological Research Program   (United States)

more..

Author keywords

Age; ApoE; Cognition; HIV disease

Indexed keywords

APOLIPOPROTEIN E4; GENOMIC DNA;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALLELE; ARTICLE; CAUCASIAN; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEN WHO HAVE SEX WITH MEN; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TIME OF DEATH; ANCESTRY GROUP; CLINICAL TRIAL; COGNITION; COMPLICATION; GENE EXPRESSION; GENETICS; MALE HOMOSEXUALITY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGY; SURVIVAL; VERY ELDERLY; VIROLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; COGNITION; CONTINENTAL POPULATION GROUPS; EDUCATIONAL STATUS; GENE EXPRESSION; GENOTYPE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84925513661     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0290-2     Document Type: Article

References (40)

1. Andres MA, Feger U, Nath A, Munsaka S, Jiang CS, Chang L (2010) APOE epsilon 4 allele and CSF APOE on cognition in HIV-infected subjects. J Neuroimmune Pharmacol 6(3):389–398
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799
3. Becker JT, Kingsley LA, Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Selnes OA (2014) “Cohort profile: recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.” Int J Epidemiol
4. Beydoun MA, Beydoun HA, Kaufman JS, An Y, Resnick SM, O'Brien R, Ferrucci L, Zonderman AB (2013) Apolipoprotein E epsilon4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults. J Am Geriatr Soc 61(4):525–534
5. Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES (1996) Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 7(3):169–174
6. Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008) Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A 105(25):8718–8723
7. Chang L, Andres M, Sadino J, Jiang CS, Nakama H, Miller E, Ernst T (2011) Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 58(4):1017–1027
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261(5123):921–923
9. Drenos F, Kirkwood TB (2010) Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E. PLoS ONE 5(4):e10022
10. Guang-da X, You-ying L, Zhi-song C, Yu-sheng H, Xiang-jiu Y (2004) Apolipoprotein e4 allele is predictor of coronary artery disease death in elderly patients with type 2 diabetes mellitus. Atherosclerosis 175(1):77–81
11. Hoare J, Westgarth-Taylor J, Fouche JP, Combrinck M, Spottiswoode B, Stein DJ, Joska JA (2012) “Relationship between apolipoprotein E4 genotype and white matter integrity in HIV-positive young adults in South Africa.” Eur Arch Psychiatry Clin Neurosci
12. Hoenig JM, Heisey DM (2001) “The abuse of power: the pervasive fallacy of power calculations in data analysis.” The American Statistician 55(19–24)
13. Jarvik GP (1997) Genetic predictors of common disease: apolipoprotein E genotype as a paradigm. Ann Epidemiol 7(5):357–362
14. Joska JA, Combrinck M, Valcour VG, Hoare J, Leisegang F, Mahne AC, Myer L, Stein DJ (2010) Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neurovirol 16(5):377–383
15. Kingsley LA, Cuervo-Rojas J, Munoz A, Palella FJ, Post W, Witt MD, Budoff M, Kuller L (2008) Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS 22(13):1589–1599
16. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA (2006) Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry 63(5):484–489
17. Kulminski AM, Arbeev KG, Culminskaya I, Arbeeva L, Ukraintseva SV, Stallard E, Christensen K, Schupf N, Province MA, Yashin AI (2014) Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan. PLoS Genet 10(1):e1004141
18. Lane KA, Gao S, Hui SL, Murrell JR, Hall KS, Hendrie HC (2003) Apolipoprotein E and mortality in African-Americans and Yoruba. J Alzheimers Dis JAD 5(5):383–390
19. Lee JH, Tang MX, Schupf N, Stern Y, Jacobs DM, Tycko B, Mayeux R (2001) Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 103(2):121–127
20. Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106–118
21. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852):622–630
22. Menzel HJ, Kladetzky RG, Assmann G (1983) Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3(4):310–315
23. Miller EN, Selnes OA, McArthur MB (1990) Neuropsychological test performance in HIV1-infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 40:197–203
24. Miller EN, Satz P, Visscher B (1991) Computerized and conventional neuropsychological assessment of HIV1-infected homosexual men. Neurology 41(10):1608–1616
25. Moore CG, Carter RE, Nietert PJ, Stewart PW (2011) Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci 4(5):332–337
26. Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB (2013) “Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.” J Neurovirol
27. Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ (2013) Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity. Neurobehav HIV Med 5:11–22
28. Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
29. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L (2009) APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging 30(10):1545–1551
30. Selnes OA, Miller EN (1994) Development of a screening battery for HIV-related cognitive impairment: the MACS experience. Neuropsychology of HIV Infection. I. Grant and A. Martin. Oxford University Press, New York, pp 176–190
31. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37(2):268–285
32. Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL (2012) Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 26(18):2327–2335
33. Spector SA, Singh KK, Gupta S, Cystique LA, Jin H, Letendre S, Schrier R, Wu Z, Hong KX, Yu X, Shi C, Heaton RK (2010) APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS 24(10):1471–1479
34. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90(5):1977–1981
35. Sun B, Abadjian L, Rempel H, Calosing C, Rothlind J, Pulliam L (2010) Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J Neurovirol 16(2):115–124
36. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM (1994) ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb J Vasc Biol Am Heart Assoc 14(10):1617–1624
37. Valcour V, Shiramizu B, Shikuma C (2008) Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival. Proc Natl Acad Sci U S A 105(41):E66, author reply E67-68
38. Wardell MR, Suckling PA, Janus ED (1982) Genetic variation in human apolipoprotein E. J Lipid Res 23(8):1174–1182
39. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26(6):759–778
40. Zuo L, van Dyck CH, Luo X, Kranzler HR, Yang BZ, Gelernter J (2006) Variation at APOE and STH loci and Alzheimer’s disease. Behav Brain Funct 2:13